Université Libre de Bruxelles
Aquaporin-1 as a novel potential therapeutic target in proliferative vitreoretinal diseases
2022
Ixelles
Supported project of François Willermain : 'AQP1 is involved in proliferative vitreoretinopathy (PVR), a vision-threatening disease that is on the rise due to the increasing cases of diabetic retinopathy, myopia, and retinal detachment (RD). Surgery is currently the only treatment of PVR and RD but is also a risk factor of PVR and RD. This project aims to study the role of AQP1 and its regulation by DNA methylation in PVR and would be the first major step towards establishing AQP1 as therapeutic targets in ocular proliferative diseases'